胎儿可存活前未足月胎膜早破的产前管理:CNGOF胎膜早破指南
本指南由法国国家妇产科医师学院制定,基于PubMed、Cochrane图书馆及法国内外妇产科协会推荐,评估可存活前胎膜早破(PROM)的母婴预后及干预措施。该事件罕见(频率0.3–1%),23–39%孕妇在PROM后一周内分娩,近40%在两周后仍未分娩;期待治疗者住院存活率17–55%,无重大疾病存活率26–63%;母体脓毒症频率0.8–4.8%。推荐确诊PROM即预防性抗生素,预计分娩且孕周至32周者产前给予硫酸镁(Grade A),不推荐宫缩抑制剂。因证据等级低,多数推荐基于专业共识。
要点
- 可存活前PROM确诊后即推荐预防性抗生素治疗(专业共识)。
- 从决定进行新生儿复苏起至孕32周,对即将分娩的孕妇推荐给予硫酸镁(Grade A)。
- 此情境下不推荐宫缩抑制剂(专业共识)。
- 无宫内感染证据时,无理由推荐住院管理优于院外管理(专业共识)。
- 可在初始评估及孕周持续7–14天后超声评估羊水量(专业共识)。
适用人群与场景
- 可存活前胎膜早破(previable PROM)的孕妇。
- 作为羊膜腔穿刺并发症发生的PROM,预后通常优于自发性PROM(NP3)。
处置流程与药物剂量
- 向孕妇及其伴侣提供信息是照护的重要组成部分(专业共识)。
- 可存活前PROM后可提议初始住院一段时间(专业共识)。
- 此后,当无支持宫内感染的证据时,无理由推荐住院管理优于院外管理(专业共识)。
- 可在初始评估时及孕周持续7–14天后超声评估羊水量(专业共识)。
- 一旦诊断PROM即推荐预防性抗生素治疗(专业共识)。
- 可提议糖皮质激素治疗的孕周取决于所选定的新生儿复苏阈值,尤其需考虑父母意愿(专业共识)。
- 从决定进行新生儿复苏起至孕32周,对即将分娩的孕妇推荐给予硫酸镁(Grade A)。
- 此情境下不推荐宫缩抑制剂(专业共识)。
研究设计与关键结果
- 可存活前PROM是罕见事件,据估计频率为0.3–1%(NP4)。
- 23–39%的孕妇在PROM后一周内分娩,近40%在两周后仍未分娩(NP3)。
- 医学终止妊娠的频率因研究而异(NP4),胎儿死亡频率亦然(NP4)。
- 在保守治疗患者中,住院存活率及无重大疾病存活率分别为17–55%和26–63%(NP4)。
- 新生儿预后主要取决于早产及其并发症(NP3)。
- 在最近的研究中,母体脓毒症频率为0.8–4.8%(NP4)。
- 仅报告一例母体死亡,而2007年至2012年间法国确认了3例(NP3)。
证据类型、等级与局限
- 证据类型:指南(CNGOF胎膜早破指南),基于PubMed、Cochrane图书馆及法国内外妇产科协会推荐制定。
- 证据等级:采用NP3、NP4及Grade A、专业共识等级别。
- 局限:关于可存活前PROM管理的科学工作证据等级低,因此所提出的大多数推荐基于专业共识,系对适用于更晚孕周的推荐进行「合理」外推。
对床旁实践的改变
- 确诊可存活前PROM即启动预防性抗生素(专业共识),改变既往可能犹豫的做法。
- 预计32周前分娩且决定新生儿复苏者,产前给予硫酸镁(Grade A),不推荐宫缩抑制剂(专业共识)。
- 无宫内感染证据时,无需强制住院,可院外管理(专业共识),适用于血流动力学稳定、能及时复诊者。
- 糖皮质激素使用孕周需结合新生儿复苏阈值及父母意愿决定(专业共识),不是固定用于所有可存活前PROM。
- 羊水量超声评估可在初始及7–14天后进行(专业共识),不是每日监测的推荐。
指南或共识出处
- CNGOF胎膜早破指南(CNGOF Preterm Premature Rupture of Membranes Guidelines),法国国家妇产科医师学院,发表于Gynecol Obstet Fertil Senol。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the maternal, perinatal and long-term prognosis in the event of previable premature rupture of the membranes (PROM) and to specify the interventions likely to reduce the risks and improve the prognosis.
METHODS: The PubMed database, the Cochrane Library and the recommendations from the French and foreign obstetrical societies or colleges have been consulted.
RESULTS: Previable PROM is a rare event whose frequency varies from 0.3 to 1% according to estimates (NP4). When occurring as a complication of amniocentesis, the prognosis is generally better than when spontaneous (NP3). Between 23 and 39% of women will deliver in the week following PROM and nearly 40% of women will not have given birth 2 weeks after (NP3). The frequency of medical termination of pregnancy varies greatly according to the studies (NP4), as does that of fetal death (NP4). Hospital survival and survival rates without major morbidity as a proportion of conservatively treated patients range from 17-55% and 26-63%, respectively (NP4). Neonatal prognosis is largely dominated by prematurity and its complications (NP3). The frequency of maternal sepsis varies from 0.8 to 4.8% in the most recent studies (NP4). Only one case of maternal death is reported, although 3 cases were identified in France between 2007 and 2012 (NP3). Information is a major component of the care to be provided to women and their partners (Professional consensus). An initial period of hospitalization may be proposed after previable PROM (Professional consensus). Thereafter, there is no argument to recommend hospital management rather than extra-hospital management when there is no argument in favour of intrauterine infection (Professional consensus). An evaluation of the amount of amniotic fluid by ultrasound may be proposed at the initial consultation and after a period of 7 to 14 days if pregnancy continues (Professional consensus). Prophylactic antibiotic treatment is recommended as soon as PROM is diagnosed (Professional consensus). The gestational age at which corticosteroid therapy may be proposed will depend on the thresholds selected for neonatal resuscitation care. In particular, it will take into account parental positioning (Professional consensus). From the time of the decision to perform neonatal resuscitation until the gestational age of 32 weeks, it is recommended to administer MgSO4 to the woman whose delivery is imminent (Grade A). Tocolysis is not recommended in this context (Professional consensus). In certain situations, meeting strictly the conditions mentioned by the CSP article L. 2213-1, a maternal request for medical interruption of pregnancy may be discussed.
CONCLUSION: The levels of evidence of scientific work on the management of previable PROM are low, therefore, most of the recommendations proposed here are based on professional agreement by "reasonable" extension of recommendations valid for later gestational ages.
参考来源
- Azria E. [Antenatal management in case of preterm premature rupture of membranes before fetal viability: CNGOF Preterm Premature Rupture of Membranes Guidelines]. Gynecol Obstet Fertil Senol. 2018. PMID: 30409732. doi:10.1016/j.gofs.2018.10.023
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。